CME Group Inc. $CME Stock Purchased by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. lifted its stake in CME Group Inc. (NASDAQ:CME) by 9.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,720 shares of the financial services provider’s stock after buying an additional 5,427 shares during the period. Rakuten Investment Management Inc.’s holdings in CME Group were worth $17,036,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Whipplewood Advisors LLC grew its position in CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares during the last quarter. First Community Trust NA bought a new position in CME Group in the 3rd quarter valued at $26,000. North Point Portfolio Managers Corp OH bought a new position in CME Group in the 3rd quarter valued at $26,000. Mowery & Schoenfeld Wealth Management LLC acquired a new position in CME Group in the second quarter worth $28,000. Finally, Main Street Group LTD acquired a new stake in shares of CME Group in the first quarter valued at $32,000. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In related news, insider Julie Winkler sold 10,079 shares of the stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $305.15, for a total transaction of $3,075,606.85. Following the transaction, the insider directly owned 21,482 shares of the company’s stock, valued at $6,555,232.30. This represents a 31.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Sunil Cutinho sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total value of $1,493,500.00. Following the transaction, the insider directly owned 20,037 shares in the company, valued at approximately $5,985,051.90. This trade represents a 19.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 32,979 shares of company stock worth $9,552,762 over the last quarter. Insiders own 0.30% of the company’s stock.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: October weekend trading in crypto reportedly reached a record $1.3 billion on CME, while coverage also highlights record trading volumes. Sustained activity could lift transaction-related revenue. Weekend crypto trading article Record trading volumes article
• Positive Sentiment: CME Group’s market-data revenue reached a record $243 million last quarter, adding a recurring revenue source alongside trading fees. Market-data revenue article
• Neutral Sentiment: The CFTC’s approval of stock perpetual futures for U.S. registered exchanges could expand the futures market, but the report does not establish how much CME Group may benefit. CFTC stock perpetual futures article
• Negative Sentiment: Two insiders sold shares on Nov. 2: Julie Winkler sold 10,079 shares, reducing her position by about 32%, and director Howard Siegel sold 2,000 shares, cutting his holdings by about 9%. Such sales may weigh on sentiment, although both retained shares. Insider sales report

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CME. Weiss Ratings raised shares of CME Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Friday, October 23rd. TD Cowen increased their price objective on shares of CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a report on Monday, October 5th. Deutsche Bank Aktiengesellschaft cut shares of CME Group from a “buy” rating to a “hold” rating and reduced their price objective for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. Wall Street Zen raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Saturday, October 31st. Finally, Wells Fargo & Company upped their target price on shares of CME Group from $315.00 to $333.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Ten investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $314.44.

CME Group Stock Up 1.4%

CME opened at $308.27 on Thursday. The stock’s fifty day simple moving average is $282.08 and its 200 day simple moving average is $280.52. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The stock has a market cap of $110.34 billion, a PE ratio of 25.29, a price-to-earnings-growth ratio of 3.71 and a beta of 0.15. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, beating the consensus estimate of $2.99 by $0.03. The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. CME Group’s revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the company posted $2.68 earnings per share. As a group, research analysts expect that CME Group Inc. will post 12.34 earnings per share for the current year.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.